Watermark

BGB-3111-302

Completed

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström’s Macroglobulinemia (WM)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-302

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2016-002980-33

Protocol Summary

 

 

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary